Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
October 27, 2026
Dr. Christopher Li shares vision for Public Health Sciences Division
‘We don’t want our work to just sit in academic journals, but to impact community’
Lobular community celebrates 10 years of progress, vows to ‘keep pedaling’
Patient advocates, clinicians and researchers gather for 2026 ILC Symposium; Fred Hutch joins LARC, new lobular research consortium
Fred Hutch researchers look at longevity in older women, metabolic signatures of vaginitis
Two prestigious R01 NIH grants awarded to Drs. Alex Reiner, Sujatha Srinivasan
When both cancer and courage run in the family
Two Seattle sisters, both diagnosed with BRCA2-driven breast cancer, speak out on importance of genetic testing for hereditary cancers
New assay better predicts treatment for two cancers
Fred Hutch researchers develop HRDefine, a new clinical test to better serve patients with tubo-ovarian and triple-negative breast cancer
Living with the long-term side effects of prostate cancer, from sexual to spiritual
In this episode of Bench to Bedside and Beyond, we talk to a prostate cancer patient and the director of the Fred Hutch Sexual Health Clinic
Dr. Lynn Symonds receives ASCO Career Development Award
‘Homegrown’ Fred Hutch clinician-scholar honored for research on triple-negative breast cancer
After cancer treatment, emotional and spiritual health is key to maintaining equilibrium
In this episode of Bench to Bedside and Beyond, we talk to a bone marrow transplant survivor and the director of psychiatry at Fred Hutch
Small cell lung cancer research gets a boost
Drs. David MacPherson and Gavin Ha receive $1.5M from Andy Hill CARE Fund to create much-needed liquid biopsy for SCLC
Science-backed solutions for dealing with wildfire smoke, pollutants
Fred Hutch creates resources for wildfire smoke, air pollution; new digital health intervention alerts vulnerable patients to harmful pollution
Sidelining cancer treatment’s side effects through exercise, nutrition, prehab and rehab
In this episode of Bench to Bedside and Beyond, we talk to a prostate cancer survivor and the medical director of Fred Hutch’s cancer rehab about treatment’s aftermath
FDA approves new breast cancer drug based on VIKTORIA-1 study results
New targeted drug brings ‘big change, big benefit,’ per Fred Hutch’s Dr. Sara Hurvitz, who led the study
Red meat in moderation: better for you, better for the environment
Don’t forget to add some green veggies to those red-white-and-blue barbecues!
Here comes the sun! What’s your skin strategy?
Avoiding sunburn is the first step in preventing deadly skin cancer melanoma
Beyond the 5-year myth: How survivorship care helps cancer patients live well
In this episode of From Bench to Bedside and Beyond, we discuss why Survivorship programs exist and how Fred Hutch’s program is changing to better serve patients
Lung cancer researchers, advocates gather in Seattle
SPORE scientists talk T cells, new targeted therapies, the tumor microenvironment and more at annual meeting
Pancreatic cancer experts, patients applaud new KRAS inhibitor therapy
Hope for patients and oncologists: ‘We’re at the beginning of a paradigm shift’
From treatment to thriving: Redefining cancer survivorship
In this episode of From Bench to Bedside and Beyond, we discuss how the growing field of survivorship supports patients as they navigate what's next
What cancer researchers, clinicians and patients say about ‘game-changing’ GLP-1s
Yes, you lose weight, but there are definitely trade-offs; cancer prevention role of new weight loss drugs still being studied
Is there a way to boost immunotherapy response?
American Cancer Society grant will fund new analysis of how advanced melanoma evades the immune system